Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cns Pharmaceuticals Inc
(NQ:
CNSP
)
0.1956
-0.0134 (-6.41%)
Streaming Delayed Price
Updated: 3:59 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Cns Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Broad Cancer Analysis Finds Possibility for Tumor Reduction in Nearly All Cancers
April 05, 2023
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces FY 2022 Results, Corporate Update
April 03, 2023
Via
Investor Brand Network
CNS Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate Update
April 03, 2023
Via
ACCESSWIRE
AI Screens Brain Tumor Genes in Less Than Two Minutes
March 30, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation in Upcoming Virtual Investor Event
March 29, 2023
Via
Investor Brand Network
Study Finds Repeated Head Trauma Increases Brain Cancer Risk
March 07, 2023
Via
Investor Brand Network
Lighting Up Malignant Tissues Could Boost Precision of Surgical Removal
March 24, 2023
Via
Investor Brand Network
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Hits Key Milestone in Global GBM Clinical Trial with the Enrollment of First Patient in Spain
March 24, 2023
Via
Investor Brand Network
Normalizing Blood Vessels in Tumors Could Improve Brain Cancer Immunotherapy
March 20, 2023
Via
Investor Brand Network
Research Suggests Brain Cancers Could Be Detected Via Blood Tests
March 14, 2023
Via
Investor Brand Network
Topics
Death
Exposures
Death
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces It Has No Exposure to Silicon Valley Bank Issues
March 13, 2023
Via
Investor Brand Network
Researchers Find That Nutraceuticals May Be Useful in Preventing and Treating Cancer
January 23, 2023
Via
Investor Brand Network
Topics
Death
Exposures
Death
Study Documents Dangers of Halting Opioid Treatments for Chronic Pain
March 09, 2023
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Enrolls First Patient in Switzerland in Potentially Pivotal Berubicin Trial
March 09, 2023
Via
Investor Brand Network
Researchers Find Ways to Ease Cancer Treatment Outcome Prediction
February 23, 2023
Via
Investor Brand Network
New AI Tool Helps Personalize Breast Cancer Therapy
February 17, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Research Finds Most Pediatric Oncologists Don’t Discuss Prognosis with Caregivers
February 14, 2023
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Enrolls First Patient in Spain in Key Global Trial Studying Berubicin for Treatment of GBM
February 07, 2023
Via
Investor Brand Network
Study Finds Boosting White Blood Cell Counts May Improve Treatment Outcomes
February 06, 2023
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Pleased with Early Results from Global Clinical Trial
February 03, 2023
Via
Investor Brand Network
Study Determines That How Proteins Move May Influence Brain Tumor Growth
January 30, 2023
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Discusses ‘Lifeblood’ of Phase 2 Berubicin Trial
January 24, 2023
Via
Investor Brand Network
Researchers Design a New Way to Kill Cancer Using Cancer Cells
January 13, 2023
Via
Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin to Be Evaluated in Investigator-Initiated Phase 1b/2 Trial
January 12, 2023
Via
Investor Brand Network
JTC Team to Host the Virtual Investor 2023 Companies to Watch Event on January 17th, 18th, and 19th
January 11, 2023
Via
ACCESSWIRE
TinyGemsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Poised to Potentially Change History
January 09, 2023
Via
Investor Brand Network
TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at Virtual Investor 2023 ‘Companies to Watch’
January 05, 2023
Via
Investor Brand Network
Four Developments in Cancer Research That Occurred in 2022
January 05, 2023
Via
Investor Brand Network
Topics
Death
Exposures
Death
Product Safety
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Strategic Board Appointment of Faith L. Charles, JD
January 03, 2023
Via
Investor Brand Network
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Continues to See Growth in Patient Enrollment for Brain Cancer Drug Candidate Global Clinical Trial
December 28, 2022
Via
Investor Brand Network
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.